Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer
Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer
复制标题
人甲状腺癌中 N-Myc 下游调节基因 2 表达降低
DOI:
10.1186/1471-2407-8-303
复制
发表时间:
2008-10-22
期刊:
影响因子:
3.8
通讯作者:
Yao, Libo
中科院分区:
文献类型:
--
作者:
Zhao, Huadong;Zhang, Jian;Yao, Libo
BackgroundNDRG2 (N-Myc downstream-regulated gene 2) was initially cloned in our laboratory. Previous results have shown thatNDRG2 expressed differentially in normal and cancer tissues. Specifically,NDRG2 mRNA was down-regulated or undetectable in several human cancers, and over-expression ofNDRG2 inhibited the proliferation of cancer cells.NDRG2 also exerts important functions in cell differentiation and tumor suppression. However, it remains unclear whetherNDRG2 participates in carcinogenesis of the thyroid.MethodsIn this study, we investigated the expression profile of humanNDRG2 in thyroid adenomas and carcinomas, by examining tissues from individuals with thyroid adenomas (n = 40) and carcinomas (n = 35), along with corresponding normal tissues. Immunohistochemistry, quantitative RT-PCR and western blot methods were utilized to determine both the protein and mRNA expression status of Ndrg2 and c-Myc.ResultsThe immunostaining analysis revealed a decrease of Ndrg2 expression in thyroid carcinomas. When comparing adenomas or carcinomas with adjacent normal tissue from the same individual, the mRNA expression level ofNDRG2 was significantly decreased in thyroid carcinoma tissues, while there was little difference in adenoma tissues. This differential expression was confirmed at the protein level by western blotting. However, there were no significant correlations ofNDRG2 expression with gender, age, different histotypes of thyroid cancers or distant metastases.ConclusionOur data indicates thatNDRG2 may participate in thyroid carcinogenesis. This finding provides novel insight into the important role ofNDRG2in the development of thyroid carcinomas. Future studies are needed to address whether the down-regulation ofNDRG2 is a cause or a consequence of the progression from a normal thyroid to a carcinoma.